Related Experiment Video
Updated: May 26, 2026

Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
A case of sibutramine-induced hyperprolactinemia
Carolina Garcia Soares Leaes1, Júlia Fernanda Semmelmann Pereira-Lima, Miriam da Costa Oliveira
1Neuroendocrinology Center of Santa Casa de Porto Alegre, UFCSPA, Brazil. dracarolina@cisa.med.br
Sibutramine, used for obesity management, can induce hyperprolactinemia, a condition causing elevated prolactin levels. This case highlights the need to consider sibutramine in the differential diagnosis of drug-induced hyperprolactinemia.
Area of Science:
- Endocrinology
- Pharmacology
- Internal Medicine
Background:
- Hyperprolactinemia is a known side effect of certain medications, particularly antipsychotics and prokinetic agents.
- Elevated prolactin levels typically normalize within days of drug cessation.
- Sibutramine, an appetite suppressant, has not been previously linked to altered prolactin levels.
Related Concept Videos
Hyperthyroidism I: Introduction
Hyperthyroidism II: Pathophysiology
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
A study on guinea pigs examined the...
Cushing Syndrome II: Pathophysiology
Major Hormones and Their Functions
Oxytocin, produced in the hypothalamus and released by the pituitary gland, plays a role in social bonding, childbirth, and lactation.
Cushing Syndrome I: Introduction
